Efficient targeting of HER-2-positive cancers by Antibody-Coupled T cell Receptor (ACTR) engineered autologous T cells-MedSci.cn

Efficient targeting of HER-2-positive cancers by Antibody-Coupled T cell Receptor (ACTR) engineered autologous T cells

Judge, CB; DeBarge, R; Choi, E; O'Callaghan, K; Edwards, L; Schultes, B; Ettenberg, S; Huet, HA

CANCER IMMUNOLOGY RESEARCH, 2017; 5 (3):

科室
- - 订阅+
  - 更多科室
工具
服务